February 13, 2025

FDA Approves Extended Label for Avacincaptad Pegol

The new label removes limitations on the duration of dosing.

Conexiant

February 03, 2025

EssilorLuxottica Receives FDA Clearance for Nuance Audio Smart Glasses

Sales are expected to begin in the United States in Q1, and in Italy, France, Germany, and the United Kingdom in the first half of 2025.

Conexiant

January 27, 2025

CIA Shifts Stance on COVID-19 Origins

"Now, the most important thing is to make China pay for unleashing a plague on the world."

Conexiant

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant

November 15, 2024

Eyenovia Halts Eye Drug Trial

Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.

Reuters

March 01, 2024

EDITOR'S PERSPECTIVE

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

August 15, 2024

Major Medicare Drug Price Cuts Announced

Biden administration secures up to 79% in reductions on top-selling medications.

Reuters

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters